Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society exists to find cures and to be a resource for local patients and families who are battling blood cancers, over 1 million nationwide. Every 3 minutes someone is newly diagnosed with a blood cancer and every 10 minutes someone loses the fight. Since its inception in 1949, LLS has been seeking to find cures by investing in cutting edge research for new treatments and to help patients live longer, healthier lives. LLS has funded ground breaking research, leading to 55 of the 65 newly approved drugs by the FDA, being funded by LLS. LLS also provides over $10 million locally to North Texas per year for co-pay, travel assistance, and urgent need financial support for patients upon diagnosis. LLS also serves to be resource for patients and families through the First Connection Program, support groups and nutritional services. The Information Resource Center helps navigate through clinical trials, information, nutrition, and community support.

Our Needs

The Leukemia & Lymphoma Society (LLS) funds research towards new treatments and cures for those battling blood cancers and, in turn, other types of cancer. The need for cures is critical. LLS provides patients and families with emotional, educational and financial support while navigating through their cancer diagnosis and treatment.

Whether you are donating to help patients with financial assistance; donating to one of our impactful campaigns; or donating to ensure we continue revolutionizing pediatric cancer care through our Dare to Dream Initiative and other research...Your support is needed NOW more than ever! Consider a gift today to demonstrate to our patients and families that they are not alone.

Help us spread this message of hope to our patients - You can endure the difficulty of cancer, and you never have to fight alone.

Facts about blood cancer:

• There are 1.6M people in the U.S. living with or in remission from leukemia, lymphoma, myeloma, MDS or MPNs 
• Blood cancers account for 39.0% of all cancers in the 20 years & under-age group.  Based on 2013-2017 data
• Approximately every 3 minutes, one person in the US is diagnosed with leukemia, lymphoma or myeloma
• Approximately every 9 minutes, someone in the US dies from a blood cancer. 
• Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 57,750 people in the US in 2021.

LLS Impact:

• LLS has helped advance more than 70% of the 110 blood cancer treatment approvals in the last 6 years.
• Since 1949, LLS has contributed more than $1.6 billion to cancer research 
• In 2021, LLS dedicated $35 million in new multi-year funding to support more than 260 active research programs
• The Patti Robinson Kaufmann First Connection® Program matched more than 2,000 patients with trained volunteers facing the same disease, helping to avert pandemic-related isolation. In addition, membership in LLS Community—our online social network—increased to more than 19,000 individuals. 
• In 2022, LLS Information Specialists responded to approximately 26,000 inquiries from patients and caregivers.
• LLS awarded 100 scholarships to young adult blood cancer survivors in 2022, and 105 scholarships in 2023.